Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
NAD (nicotinamide adenine dinucleotide) supplementation and GLP-1 receptor agonists like tirzepatide work through different biological pathways—one targeting cellular energy and mitochondrial function, the other regulating appetite and metabolism. Many patients wonder whether stacking these interventions creates a synergistic effect or introduces unforeseen interactions. This guide clarifies what current evidence shows and how PlexusDx tailors GLP-1 therapy to your individual metabolic profile.
How NAD and GLP-1 Medications Work in the Body
NAD is a coenzyme involved in redox reactions that power cellular respiration, DNA repair, and sirtuin activation—genes associated with longevity and metabolic health. When NAD levels drop with age or metabolic dysfunction, cells struggle to generate energy efficiently, potentially slowing weight loss and increasing fatigue. GLP-1 medications like tirzepatide, by contrast, activate glucagon-like peptide-1 receptors in the brain and pancreas, suppressing hunger signals, slowing gastric emptying, and improving insulin sensitivity. These are fundamentally different mechanisms: NAD works at the mitochondrial level, while GLP-1 operates through neuroendocrine pathways.
Research into GLP-1 therapy shows sustained weight loss of 15–22% over 68 weeks in clinical trials, with improvements in cardiovascular risk markers and metabolic syndrome features. NAD precursors (like nicotinamide riboside or NMN) have demonstrated modest metabolic benefits in some animal and preliminary human studies, but large-scale clinical trials in humans remain limited. The question of combination therapy hinges on whether boosting cellular energy with NAD enhances the satiety and metabolic benefits of GLP-1, or whether the two interventions simply operate independently without meaningful interaction.
Safety Profile: Can You Take NAD with Zepbound or Tirzepatide?
No major pharmacokinetic or pharmacodynamic interactions have been documented between NAD supplements and GLP-1 receptor agonists in published literature. NAD precursors are water-soluble B-vitamin derivatives that are processed through the kidney and liver, while tirzepatide is a long-acting injectable peptide metabolized through linear peptidase degradation and renal clearance—different elimination routes mean direct drug–drug competition is unlikely. However, the absence of reported interactions does not constitute proof of safety in all contexts, especially for individuals with hepatic impairment, renal disease, or concurrent medications that affect glucose metabolism.
Patients taking both agents should monitor for signs of hypoglycemia (shakiness, sweating, confusion), particularly if they are also on insulin or sulfonylureas, because GLP-1 medications lower blood glucose and NAD-boosting compounds may theoretically potentiate this effect in susceptible individuals. Gastrointestinal side effects—nausea, vomiting, constipation, or diarrhea—are common with GLP-1 therapy and may be compounded if NAD supplements trigger additional GI symptoms in sensitive users. Any patient considering this combination should discuss it with their healthcare provider and track symptom patterns closely during the first 2–4 weeks.
Does NAD Supplementation Enhance GLP-1 Weight Loss Outcomes?
Current evidence does not provide strong support for combining NAD with GLP-1 medications to amplify weight loss beyond what GLP-1 alone achieves. GLP-1 monotherapy has demonstrated robust appetite suppression and metabolic improvements in thousands of patients across multiple randomized trials; adding NAD has not been studied in a head-to-head trial, so the additive benefit remains speculative. Some theorists propose that restoring mitochondrial NAD levels could improve exercise tolerance or reduce weight-loss fatigue, allowing patients to sustain higher activity levels—an indirect pathway to enhanced outcomes. However, this mechanism remains unproven in humans and does not justify the added cost and complexity of dual supplementation without medical guidance.
PlexusDx recommends focusing first on optimizing GLP-1 dosing and compound selection (semaglutide versus tirzepatide, injection versus oral) based on your individual metabolic genetics before adding complementary agents. The Precision Peptide Genetic Test analyzes key variants in the GLP1R, GIPR, FTO, and MC4R genes—pathways that directly influence GLP-1 efficacy and dose requirements. Once your GLP-1 regimen is personalized and you've achieved stable weight loss, adding NAD or other metabolic supports can be discussed with your provider as a potential maintenance or optimization step.
Optimizing Your Weight Loss Plan at PlexusDx
PlexusDx offers compounded tirzepatide injection starting at $249/month through licensed 503A compounding pharmacies, eliminating the premium markup of brand-name Zepbound while maintaining pharmaceutical quality and potency. Unlike many weight-loss programs that charge per-dose or escalate pricing with dose increases, PlexusDx commits to flat-rate monthly pricing—your dose may need to go up, but your price won't. All medications are available in all 50 states without insurance requirements, and HSA/FSA accounts cover the cost, making precision weight loss accessible to a broader population.
The Precision Peptide Genetic Test ($99 add-on after your first month of treatment) identifies which GLP-1 compound and dose strategy will work best for your biology by examining 49 peptides across 14 metabolic pathways. This data-driven approach reduces trial-and-error, accelerates results, and allows you to make informed decisions about whether adding supplements like NAD truly aligns with your personalized metabolic profile. Your PlexusDx provider can then integrate any complementary therapies—including NAD, exercise protocols, or micronutrient support—into a comprehensive weight-loss strategy tailored to your genetics and lifestyle.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it safe to take NAD supplements while on Zepbound or tirzepatide?
No major drug interactions between NAD and GLP-1 medications have been reported in medical literature. However, both agents can affect blood sugar and GI function, so patients—especially those on insulin or with renal/hepatic disease—should inform their provider before combining them. Monitoring for hypoglycemia or unusual GI symptoms during the first 2–4 weeks is prudent.
Will adding NAD boost my weight loss results on GLP-1 therapy?
Evidence does not support a synergistic weight-loss benefit from combining NAD with GLP-1 medications. GLP-1 monotherapy achieves substantial weight loss (15–22% in clinical trials); NAD's potential role remains theoretical and unproven in humans. Focus on optimizing your GLP-1 regimen first, then consider complementary agents after discussing with your provider.
How does PlexusDx personalize GLP-1 therapy to avoid unnecessary supplements?
PlexusDx offers the Precision Peptide Genetic Test ($99 after your first month), which analyzes key variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways. This identifies which GLP-1 compound and dose strategy will work best for your biology, reducing the need for trial-and-error and helping you make informed decisions about adding other agents.
What are the main side effects of combining NAD and tirzepatide?
GLP-1 medications commonly cause nausea, vomiting, constipation, or diarrhea. NAD supplements may trigger additional GI upset in some users. Hypoglycemia risk may increase if both agents lower blood sugar. Report any worsening symptoms to your provider immediately.
Can I use the Precision Peptide Genetic Test to decide if NAD is right for me?
The Precision Peptide Genetic Test is designed to optimize GLP-1 compound and dose selection by examining peptide-pathway genetics, not to evaluate NAD responsiveness. However, once your GLP-1 therapy is personalized through genetic insights, your PlexusDx provider can assess whether NAD aligns with your specific metabolic profile and goals.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic Expensive? Understanding the Costs and Options for This Popular Medication
Navigating the Path to Zepbound: How Long Does It Take Blue Cross Blue Shield to Approve Your Weight Loss Medication?